Subtopic Deep Dive
SREBP Regulation of Cholesterol Synthesis
Research Guide
What is SREBP Regulation of Cholesterol Synthesis?
SREBP regulation of cholesterol synthesis involves sterol regulatory element-binding proteins (SREBPs) that act as membrane-bound transcription factors activated by proteolytic cleavage to drive hepatic expression of genes for cholesterol biosynthesis.
SREBPs directly activate over 30 genes dedicated to cholesterol and fatty acid synthesis in the liver (Horton et al., 2002, 3916 citations). The pathway features sterol-regulated proteolysis of SREBPs, enabling nuclear translocation and target gene regulation (Brown and Goldstein, 1997, 3764 citations). Crosstalk with LXR receptors modulates SREBP-1c expression in response to oxysterols (Repa et al., 2000, 1676 citations).
Why It Matters
SREBP dysregulation promotes hypercholesterolemia and atherosclerosis by elevating hepatic cholesterol synthesis, positioning it as a target for lipid-lowering therapies (Horton et al., 2002; Glass and Witztum, 2001). LXRs regulate SREBP-1c to control lipogenesis, influencing triglyceride homeostasis and offering pathways for metabolic disorder treatments (Repa et al., 2000; Schultz et al., 2000). Bile acids suppress SREBP-1c via FXR-SHP signaling, reducing VLDL secretion and serum triglycerides in hypertriglyceridemia models (Watanabe et al., 2004).
Key Research Challenges
Proteolytic Processing Mechanisms
SREBP activation requires sequential cleavage by S1P and S2P proteases in response to sterol levels, but precise regulation remains unclear (Brown and Goldstein, 1997). Challenges include dissecting compartmentalization in the ER-Golgi axis. Over 3700 citations highlight its centrality, yet gaps persist in dynamic modeling.
LXR-SREBP Crosstalk Dynamics
Oxysterol-activated LXRs induce SREBP-1c to balance cholesterol efflux and synthesis, complicating therapeutic targeting (Repa et al., 2000). Balancing lipogenesis control without hypertriglyceridemia side effects poses issues (Schultz et al., 2000). Studies cite over 1600 papers on this interaction.
Insulin Signaling Integration
Insulin stimulates SREBP-1c processing independently of sterols, linking nutrient sensing to lipid synthesis (Eberlé et al., 2004). Challenges arise in hepatic insulin resistance models driving dyslipidemia. FXR-SHP pathways antagonize this, requiring integrated pathway analysis (Watanabe et al., 2004).
Essential Papers
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Jay D. Horton, Joseph L. Goldstein, Michael S. Brown · 2002 · Journal of Clinical Investigation · 3.9K citations
Lipid homeostasis in vertebrate cells is regulated by a family of membrane-bound transcription factors designated sterol regulatory element-binding proteins (SREBPs).SREBPs directly activate the ex...
The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor
Michael S. Brown, Joseph L. Goldstein · 1997 · Cell · 3.8K citations
Atherosclerosis
Christopher K. Glass, Joseph L. Witztum · 2001 · Cell · 3.0K citations
The Human ATP-Binding Cassette (ABC) Transporter Superfamily
Michael Dean, Andrey Rzhetsky, Rando Allikmets · 2001 · Genome Research · 1.7K citations
The ATP-binding cassette (ABC) transporter superfamily contains membrane proteins that translocate a variety of substrates across extra- and intra-cellular membranes. Genetic variation in these gen...
Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ
Joyce J. Repa, Guosheng Liang, Jiafu Ou et al. · 2000 · Genes & Development · 1.7K citations
The liver X receptors (LXRs) are members of the nuclear hormone receptor superfamily that are bound and activated by oxysterols. These receptors serve as sterol sensors to regulate the transcriptio...
Role of LXRs in control of lipogenesis
Joshua R. Schultz, Hua Tu, Alvin Luk et al. · 2000 · Genes & Development · 1.7K citations
The discovery of oxysterols as the endogenous liver X receptor (LXR) ligands and subsequent gene targeting studies in mice provided strong evidence that LXR plays a central role in cholesterol meta...
SREBP transcription factors: master regulators of lipid homeostasis
Delphine Eberlé, Bronwyn D. Hegarty, Pascale Bossard et al. · 2004 · Biochimie · 1.5K citations
Reading Guide
Foundational Papers
Start with Brown and Goldstein (1997, 3764 citations) for core proteolysis mechanism, then Horton et al. (2002, 3916 citations) for full gene program in liver; Repa et al. (2000) adds LXR regulation context.
Recent Advances
Study Eberlé et al. (2004, 1483 citations) for master regulator overview; Watanabe et al. (2004, 1325 citations) for bile acid-FXR antagonism of SREBP-1c.
Core Methods
Core techniques: sterol-regulated pulse-chase for cleavage kinetics (Brown and Goldstein, 1997); qPCR/chip for target gene induction (Horton et al., 2002); LXR agonist assays and KO mice (Repa et al., 2000; Schultz et al., 2000).
How PapersFlow Helps You Research SREBP Regulation of Cholesterol Synthesis
Discover & Search
PapersFlow's Research Agent uses searchPapers and citationGraph to map SREBP pathway founders, starting from Horton et al. (2002), revealing 3916 citations and downstream LXR works like Repa et al. (2000). exaSearch uncovers oxysterol-SREBP links, while findSimilarPapers expands from Brown and Goldstein (1997) to ABC transporter regulations.
Analyze & Verify
Analysis Agent applies readPaperContent to extract proteolytic mechanisms from Brown and Goldstein (1997), then verifyResponse with CoVe checks claims against 3764 citing papers. runPythonAnalysis enables statistical verification of citation networks or gene expression data from Horton et al. (2002), with GRADE scoring evidence strength for LXR-SREBP interactions.
Synthesize & Write
Synthesis Agent detects gaps in SREBP-insulin crosstalk via contradiction flagging across Eberlé et al. (2004) and Watanabe et al. (2004). Writing Agent uses latexEditText, latexSyncCitations for Horton et al. (2002), and latexCompile to generate pathway diagrams; exportMermaid visualizes proteolysis cascades.
Use Cases
"Plot SREBP target gene expression changes from LXR activation in Repa et al. 2000"
Research Agent → searchPapers('Repa SREBP LXR') → Analysis Agent → readPaperContent → runPythonAnalysis (pandas/matplotlib on extracted qPCR data) → researcher gets publication-ready cholesterol synthesis heatmap.
"Draft LaTeX figure of SREBP proteolytic pathway from Brown and Goldstein 1997"
Research Agent → citationGraph('Brown Goldstein 1997') → Synthesis Agent → gap detection → Writing Agent → latexEditText + latexGenerateFigure + latexCompile → researcher gets TikZ diagram of ER-to-nucleus translocation synced with citations.
"Find GitHub code for modeling SREBP regulation in hepatic cells"
Research Agent → paperExtractUrls (Horton 2002 supplements) → Code Discovery → paperFindGithubRepo → githubRepoInspect → researcher gets runnable Python sim of sterol feedback on 30+ target genes.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ SREBP papers: searchPapers → citationGraph → GRADE all abstracts → structured report on proteolysis vs. LXR regulation. DeepScan applies 7-step analysis to Watanabe et al. (2004): readPaperContent → CoVe verify FXR-SHP claims → runPythonAnalysis on TG data. Theorizer generates hypotheses on SREBP-ABC1 links from Costet et al. (2000).
Frequently Asked Questions
What defines SREBP regulation of cholesterol synthesis?
SREBPs are ER membrane transcription factors cleaved by S1P/S2P proteases upon low sterols, translocating to nucleus to activate HMGCR and 30+ biosynthetic genes (Brown and Goldstein, 1997; Horton et al., 2002).
What are key methods for studying SREBP pathways?
Methods include sterol depletion for activation assays, LXR agonist treatments for induction (Repa et al., 2000), and knockout mice for lipogenesis phenotyping (Schultz et al., 2000).
What are the most cited papers on SREBP regulation?
Top papers: Horton et al. (2002, 3916 citations) on liver synthesis program; Brown and Goldstein (1997, 3764 citations) on proteolysis; Repa et al. (2000, 1676 citations) on LXR-SREBP-1c.
What open problems exist in SREBP research?
Unresolved: tissue-specific SREBP isoforms in insulin resistance; therapeutic LXR activation without hypertriglyceridemia (Schultz et al., 2000); integrated modeling of FXR-LXR-SREBP feedback (Watanabe et al., 2004).
Research Cholesterol and Lipid Metabolism with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching SREBP Regulation of Cholesterol Synthesis with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Cholesterol and Lipid Metabolism Research Guide